Multi-cancer V-ATPase molecular signatures: A distinctive balance of subunit C isoforms in esophageal carcinoma-Reference-Cited by-同舟云学术

Multi-cancer V-ATPase molecular signatures: A distinctive balance of subunit C isoforms in esophageal carcinoma

Published:2020-01 Issue: Volume:51 Page:102581
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Couto-Vieira Juliana,Nicolau-Neto Pedro,Costa Evenilton Pessoa,Figueira Frederico Firme,Simão Tatiana de Almeida,Okorokova-Façanha Anna Lvovna,Ribeiro Pinto Luis Felipe,Façanha Arnoldo Rocha

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference51 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2019

3. Esophageal carcinoma;Rustgi;N Engl J Med,2014

4. Early diagnosis of oesophageal cancer;Bird-Lieberman;Br J Cancer,2009

5. The function of V-ATPases in cancer;Stransky;Physiol Rev,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells;Nature Communications;2024-07-06

2. EnsemBic: An effective ensemble of biclustering to identify potential biomarkers of esophageal squamous cell carcinoma;Computational Biology and Chemistry;2024-06

3. ATP6V1B1 regulates ovarian cancer progression and cisplatin sensitivity through the mTOR/autophagy pathway;Molecular and Cellular Biochemistry;2024-05-12

4. Tumor Microenvironment-Responsive Nanoplatforms for Triggering Drug Delivery;Handbook of Cancer and Immunology;2023-11-11

5. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming;Medical Oncology;2023-08-18